Home › Funds › Tieton Capital Management, LLC › HRMY

Tieton Capital Management, LLC position in HRMY

HARMONY BIOSCIENCES HLDGS IN · Health Care

Tieton Capital Management, LLC reported holding 305,226 shares of HRMY (HARMONY BIOSCIENCES HLDGS IN) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 3.57% of its reported portfolio and ranking #10 among its reported holdings. Tieton Capital Management, LLC has disclosed HRMY holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)305.23K sh
Reported value held$11.98M
Portfolio Weight3.57%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tieton Capital Management, LLC's HRMY position evolved

Tieton Capital Management, LLC first disclosed a stake in HRMY in Q2 2025 at 237,726 shares (US$7.5M). The position peaked in Q3 2026 at 305,226 shares, worth US$12.0M. Across 6 filings, Tieton Capital Management, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 305,226 shares valued at US$12.0M — a reduction of -1,555 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2025 (shares rose 36% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 237.73K $7.51M New
Q3 2025 298.59K $8.23M Add
Q4 2025 297.08K $11.12M Reduce
Q1 2026 311.50K $8.72M Add
Q2 2026 306.78K $11.17M Reduce
Q3 2026 305.23K $11.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HRMY and 13F data

HRMY (HARMONY BIOSCIENCES HLDGS IN) is a Health Care company. 38 other funds we track also report a position in HRMY — the largest reported positions include ARMISTICE CAPITAL, LLC (US$56.9M), Valor Management LLC (US$29.8M), venBio Partners LLC (US$17.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HRMY

All HRMY fund holders →

FAQ

How long has Tieton Capital Management, LLC held HRMY?

Tieton Capital Management, LLC has disclosed HRMY holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Tieton Capital Management, LLC's current position in HRMY?

As of Q3 2026, Tieton Capital Management, LLC holds 305.23K shares of HRMY (HARMONY BIOSCIENCES HLDGS IN), valued at $11.98M, representing 3.57% of its reported portfolio and ranking #10.

Has Tieton Capital Management, LLC been buying or selling HRMY?

In the latest 13F filing (Q3 2026), Tieton Capital Management, LLC reduced its position in HRMY. The position peaked in Q3 2026 at 305.23K shares.

Which other funds hold HRMY?

Other major institutional holders of HRMY include ARMISTICE CAPITAL, LLC, Valor Management LLC, venBio Partners LLC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.